Ansari S M, Ahmed R
Nuclear Medicine Centre, Rajshahi, Bangladesh.
Clin Nucl Med. 1989 May;14(5):354-6. doi: 10.1097/00003072-198905000-00010.
Tc-99m labelled 2,6-diethylphenylcarbamoylmethyliminodiacetic acid (EHIDA) is a non-toxic radiopharmaceutical that was found to undergo rapid biliary excretion in a normal human, with accumulation of radioactivity in the gall bladder and intestine. Images in normal subjects and nonjaundiced patients showed rapid concentration of tracer by the liver and the passage of the same into the intestine within 15 to 40 minutes, with or without visualization of the gall bladder. In the jaundiced patient, the tracer blood clearance was delayed and urinary excretion was increased. Tc-99m EHIDA has been extensively investigated in 1634 patients to evaluate its performance in the diagnosis of hepatobiliary disorders.
锝-99m标记的2,6-二乙基苯基氨甲酰甲基亚氨基二乙酸(EHIDA)是一种无毒的放射性药物,已发现其在正常人体内经胆道快速排泄,放射性在胆囊和肠道中蓄积。正常受试者和非黄疸患者的影像显示,示踪剂在15至40分钟内被肝脏快速摄取并进入肠道,胆囊可视或不可视。在黄疸患者中,示踪剂的血液清除延迟,尿排泄增加。锝-99m EHIDA已在1634例患者中进行了广泛研究,以评估其在肝胆疾病诊断中的性能。